Conference Proceedings

Safety outcomes from the clinical development programme for lisdexamfetamine dimesylate: a prodrug stimulant for the treatment of attention-deficit/hyperactivity disorder

David Coghill, Shaw Sorooshian, Beatriz Caballero

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | SPRINGER | Published : 2013